前列腺内注射氨甲环酸减少单极经尿道前列腺切除术中出血:一项随机对照临床试验
这项随机、对照、双盲试验纳入60例年龄50-85岁、前列腺重量50-80g、接受单极经尿道前列腺切除术的良性前列腺增生患者,等分为前列腺内注射1g氨甲环酸(溶于50mL 0.9%生理盐水)组和注射60mL生理盐水对照组。结果显示氨甲环酸组术中失血量及术后即刻、术后6小时冲洗液血红蛋白浓度均显著低于对照组(P<.05),两组凝血参数无显著差异且均未报告血栓栓塞事件或其他并发症。
要点
- 前列腺内注射1g氨甲环酸可显著降低单极经尿道前列腺切除术中的失血量。
- 氨甲环酸组术后即刻及术后6小时冲洗液血红蛋白浓度显著低于对照组。
- 两组凝血参数无显著差异,均未报告血栓栓塞事件或其他并发症。
核心结论
- 单极经尿道前列腺切除术中前列腺内注射氨甲环酸是安全的,不良反应极少,并能有效减少失血。
研究设计与样本
- 随机、对照、双盲试验,纳入60例年龄50-85岁、前列腺重量50-80g、接受单极经尿道前列腺切除术的良性前列腺增生患者,等分为两组。
主要发现
- 氨甲环酸组术中失血量显著低于对照组(P<.05)。
- 氨甲环酸组术后即刻冲洗液血红蛋白浓度显著低于对照组(P<.05)。
- 氨甲环酸组术后6小时冲洗液血红蛋白浓度显著低于对照组(P<.05)。
- 活化部分凝血活酶时间、凝血酶原时间、纤维蛋白原水平及凝血酶凝血时间在术前及术后6小时、24小时两组间均无显著差异。
- 两组均未报告血栓栓塞事件或其他并发症。
关键数值与推荐
- 氨甲环酸组前列腺内注射1g氨甲环酸(Cyklokapron),溶于50mL 0.9%生理盐水,多点注射。
- 对照组前列腺内注射60mL生理盐水。
临床怎么用
- 原文结论认为单极经尿道前列腺切除术中前列腺内注射氨甲环酸安全且能有效减少失血。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the role of intraprostatic injection of tranexamic acid (TXA) in reducing blood loss during transurethral resection of the prostate (TURP). METHODS: We conducted a randomized, controlled, double-blind trial involving 60 patients with benign prostatic hyperplasia aged 50-85years, undergoing monopolar TURP. Patients' prostatic weights ranged from 50 to 80 g. They were divided equally into two groups: group I received an intraprostatic injection of 1 g of TXA (Cyklokapron) dissolved in 50 mL of 0.9 % saline at multiple sites, while group II (control) received a 60 mL saline injection. Comprehensive clinical assessments and standard laboratory tests, including screenings for TXA hypersensitivity, were performed for all patients. RESULTS: Group I exhibited significantly lower intraoperative blood loss and hemoglobin concentration in irrigation fluid immediately postsurgery and at the 6-hour postoperative mark compared to group II (P < .05). Coagulation parameters-activated partial thromboplastin time, prothrombin time, fibrinogen level, and thrombin clotting time-showed no significant differences between the groups preoperatively or at 6 and 24 hours postoperatively. No thromboembolic events or other complications were reported in either group. CONCLUSION: The intraprostatic injection of TXA during monopolar TURP is safe, with minimal adverse effects, and effectively reduces blood loss. REGISTRATION: The study was registered on ClinicalTrials.gov No (ID: NCT05913466).
引用
- Diab T, El Hamshary SA, Abou Elezz A, et al. Intraprostatic Injection of Tranexamic Acid Decrease Blood Loss During Monopolar Transurethral Resection of the Prostate: A Randomized Controlled Clinical Trial. Urology. 2024. PMID: 38788904. doi:10.1016/j.urology.2024.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。